GLUCOPHAGE XR metformin hydrochloride 500mg modified release tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

metformin hydrochloride, Quantity: 500 mg

Commercializzato da:

Alphapharm Pty Ltd

INN (Nome Internazionale):

Metformin hydrochloride

Forma farmaceutica:

Tablet, modified release

Composizione:

Excipient Ingredients: hypromellose; microcrystalline cellulose; magnesium stearate; carmellose sodium

Via di somministrazione:

Oral

Confezione:

10 Tablets (Starter Pack), 120 Tablets, 60 Tablets, 90 Tablets, 100 Tablets, 30 Tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Glucophage XR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Dettagli prodotto:

Visual Identification: White to off-white, capsule shaped, biconvex tablet, debossed with "500" on one side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2006-08-02